JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid’s patent cliff esagonowsky Mon, 01/10/2022 – 14:27 More: JPM 2022: Bristol Myers plots 3 blockbuster launches to counter Revlimid's patent cliff Source: fierce
read moreJPM 2022: Amid underwhelming Aduhelm launch, Biogen supports limited Medicare coverage, exec says aliu Mon, 01/10/2022 – 11:27 More: JPM 2022: Amid underwhelming Aduhelm launch, Biogen supports limited Medicare coverage, exec says Source: fierce
read moreJPM 2022: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate $5B+ esagonowsky Mon, 01/10/2022 – 11:25 More: JPM 2022: New Johnson & Johnson CEO Duato points out 5 pipeline meds that can generate B+
read more2seventy brings in Genevant delivery tech for Novo Nordisk in vivo gene editing project ntaylor Mon, 01/10/2022 – 11:19 More: 2seventy brings in Genevant delivery tech for Novo Nordisk in vivo gene editing project Source: fierce
read moreJ&J, following in Sanofi’s footsteps, tasks i2o with oral delivery of large molecules ntaylor Mon, 01/10/2022 – 11:17 More: J&J, following in Sanofi’s footsteps, tasks i2o with oral delivery of large molecules Source: fierce
read moreSince April 2021, around 84,000 pregnant women have received at least one COVID-19 vaccination. More: Pregnant women urged to receive COVID-19 booster amid surging cases Source: News
read more© 1994 - 2022 B.M. Pharmaceuticals